Poolbeg Pharma Share Price | |
---|---|
Price | 11.30 |
Bid | 11.10 |
Ask | 11.50 |
Change | -0.50 (-4.24%) |
Volume | 314,155 |
Open | 11.45 |
High | 11.45 |
Low | 11.30 |
Prev. Close | 11.80 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 500.00m |
Market Capitalisation | £56.50m |
Market Size | 30,000 |
52 Week High | 11.90 |
52 Week High Date | 24-Apr-2024 |
52 Week Low | 6.38 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 23 |
---|---|
Vol. Sold | 158,826 |
Sold Value | £18.02k |
Vol. Bought | 155,329 |
Bought Value | £17.81k |
PE Ratio | -12.02128 |
Earnings | -0.94 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
29-Apr-24 | 10:05:39 | 11.32 | 71 | Buy* | 11.10 | 11.50 | 8.04 | O Ordinary |
29-Apr-24 | 09:47:13 | 11.347 | 9,018 | Sell* | 11.30 | 11.50 | 1,023 | O Ordinary |
29-Apr-24 | 09:46:40 | 11.347 | 250 | Sell* | 11.30 | 11.60 | 28.37 | O Ordinary |
29-Apr-24 | 09:20:55 | 11.60 | 368 | Buy* | 11.30 | 11.60 | 42.69 | O Ordinary Trade was executed as an SI |
29-Apr-24 | 09:20:55 | 11.60 | 368 | Buy* | 11.30 | 11.60 | 42.69 | O Ordinary Trade was executed as an SI |
29-Apr-24 | 09:20:55 | 11.60 | 8 | Buy* | 11.30 | 11.60 | 0.93 | O Ordinary Trade was executed as an SI |
29-Apr-24 | 09:20:55 | 11.60 | 431 | Buy* | 11.30 | 11.60 | 50.00 | O Ordinary Trade was executed as an SI |
29-Apr-24 | 09:08:01 | 11.337 | 17,746 | Sell* | 11.30 | 11.60 | 2,012 | O Ordinary |
29-Apr-24 | 08:55:43 | 11.337 | 8,147 | Sell* | 11.30 | 11.60 | 923.63 | O Ordinary |
29-Apr-24 | 08:30:22 | 11.47 | 435 | Buy* | 11.30 | 11.60 | 49.89 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
22-Feb-24 | 21-Feb-24 | Buy | Jeremy Skillington held the position of CEO at the time of this trade.Jeremy Skillington | 10.80 | GBX | 154,764 | 1,028,261 |
19-Feb-24 | 19-Feb-24 | Buy | Cathal Friel held the position of Executive Chairman at the time of this trade.Cathal Friel | 11.68 | GBX | 830,000 | 37,219,757 |
06-Oct-22 | 05-Oct-22 | Buy | Jeremy Skillington held the position of CEO at the time of this trade.Jeremy Skillington | 4.78 | GBX | 718,733 | 718,733 |
19-Jul-21 | 19-Jul-21 | Notification of Holding | Patrick J Ashe held the position of Independent Non-Executive Director at the time of this trade.Patrick J Ashe | 0.00 | 0 | 263,147 | |
19-Jul-21 | 19-Jul-21 | Notification of Holding | Cathal Friel held the position of Non-Executive Chairman at the time of this trade.Cathal Friel | 0.00 | 0 | 36,389,757 |
Welcome to Poolbeg Pharma plc which is listed on AIM (AIM:POLB). Keep up to date with our performance & latest news